Literature DB >> 21103169

Atypical depression.

Tanvir Singh1, Kristi Williams.   

Abstract

The authors conducted Pubmed searches to examine the epidemiological characteristics, symptoms, association with bipolar disorder, personality and temperament features, biology, and pharmacotherapy response of atypical depression and significance of current knowledge about this subtype of depression in treatment planning. Atypical depression has a high prevalence rate, starts early in life, tends to last longer, is more likely to occur in people with bipolar disorder, has high comorbidity of anxiety disorders, carries more risk of suicidal behavior, and has distinct personality psychopathology and biological traits. Atypical depression is an important specifier with significance in terms of predicting clinical course of depression, and hence in treatment planning and service use.

Entities:  

Keywords:  Atypical depression; epidemiology; pharmacotherapy

Year:  2006        PMID: 21103169      PMCID: PMC2990566     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  54 in total

1.  The relationship between fatigue, psychological and immunological variables in acute infectious illness.

Authors:  B K Bennett; I B Hickie; U S Vollmer-Conna; B Quigley; C M Brennan; D Wakefield; M P Douglas; G R Hansen; A J Tahmindjis; A R Lloyd
Journal:  Aust N Z J Psychiatry       Date:  1998-04       Impact factor: 5.744

2.  Symptoms of atypical depression.

Authors:  M A Posternak; M Zimmerman
Journal:  Psychiatry Res       Date:  2001-11-01       Impact factor: 3.222

3.  Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?

Authors:  Jonathan W Stewart; Patrick J McGrath; Frederic M Quitkin
Journal:  Neuropsychopharmacology       Date:  2002-02       Impact factor: 7.853

4.  Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?

Authors:  Hagop S Akiskal; Franco Benazzi
Journal:  J Affect Disord       Date:  2005-02       Impact factor: 4.839

5.  Atypical depression: clinical aspects and noradrenergic function.

Authors:  G M Asnis; L K McGinn; W C Sanderson
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

6.  Testing DSM-IV definition of atypical depression.

Authors:  Franco Benazzi
Journal:  Ann Clin Psychiatry       Date:  2003-03       Impact factor: 1.567

Review 7.  The validity of atypical depression in DSM-IV.

Authors:  R W Lam; J N Stewart
Journal:  Compr Psychiatry       Date:  1996 Nov-Dec       Impact factor: 3.735

Review 8.  Course and treatment of atypical depression.

Authors:  A A Nierenberg; J E Alpert; J Pava; J F Rosenbaum; M Fava
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 9.  Atypical depression. A valid clinical entity?

Authors:  J W Stewart; P J McGrath; J G Rabkin; F M Quitkin
Journal:  Psychiatr Clin North Am       Date:  1993-09

10.  Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.

Authors:  Jules Angst; Alex Gamma; Franco Benazzi; Vladeta Ajdacic; Dominique Eich; Wulf Rössler
Journal:  J Affect Disord       Date:  2003-01       Impact factor: 4.839

View more
  11 in total

1.  Association between cortisol levels and pain threshold in systemic sclerosis and major depression.

Authors:  Gianluca Bagnato; Francesca Cordova; Davide Sciortino; Giovanni Miceli; Antonio Bruno; Antonino Ferrera; Donatella Sangari; Giovanni Coppolino; Maria R A Muscatello; Gianluca Pandolfo; Rocco A Zoccali; William N Roberts
Journal:  Rheumatol Int       Date:  2017-10-30       Impact factor: 2.631

2.  C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination survey (NHANES) 1999-2004.

Authors:  Ruth J Hickman; Tasneem Khambaty; Jesse C Stewart
Journal:  J Behav Med       Date:  2013-04-30

3.  Sleep Duration Associated with the Lowest Risk of Depression/Anxiety in Adolescents.

Authors:  Yasutaka Ojio; Atsushi Nishida; Shinji Shimodera; Fumiharu Togo; Tsukasa Sasaki
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

4.  Behavioral activation for the treatment of atypical depression: a pilot open trial.

Authors:  Lauren M Weinstock; Mary K Munroe; Ivan W Miller
Journal:  Behav Modif       Date:  2011-04-19

5.  Assessing the Evidence of Micronutrients on Depression among Children and Adolescents: An Evidence Gap Map.

Authors:  Susan C Campisi; Clare Zasowski; Shailja Shah; Ashka Shah; Glyneva Bradley-Ridout; Daphne J Korczak; Peter Szatmari
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

6.  Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study.

Authors:  Yuka Kudo; Atsuo Nakagawa; Taisei Wake; Natsumi Ishikawa; Chika Kurata; Mizuki Nakahara; Teruo Nojima; Masaru Mimura
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-19       Impact factor: 2.570

7.  The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

Authors:  P H Rauma; J A Pasco; M Berk; A L Stuart; H Koivumaa-Honkanen; R J Honkanen; J M Hodge; L J Williams
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

8.  Reported and Recorded Sleepiness in Obesity and Depression.

Authors:  Juliane Minkwitz; Christian Sander; Hubertus Himmerich; Julia Thormann; Tobias Chittka; Ulrich Hegerl; Frank Schmidt; Monique Murray; Nihan Albayrak; Iain C Campbell; Fabian Scheipl
Journal:  Front Psychiatry       Date:  2020-04-02       Impact factor: 4.157

Review 9.  Catatonia and the immune system: a review.

Authors:  Jonathan P Rogers; Thomas A Pollak; Graham Blackman; Anthony S David
Journal:  Lancet Psychiatry       Date:  2019-06-10       Impact factor: 77.056

10.  Towards formal models of psychopathological traits that explain symptom trajectories.

Authors:  Paul B Sharp; Gregory A Miller; Raymond J Dolan; Eran Eldar
Journal:  BMC Med       Date:  2020-09-28       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.